# Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study

> **NCT06471556** · PHASE2 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 18 (estimated)

## Conditions studied

- Neuroendocrine Cell Hyperplasia of Infancy

## Interventions

- **DRUG:** IV Methylprednisolone pulses

## Key facts

- **NCT ID:** NCT06471556
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2029-02-28
- **Final completion:** 2029-02-28
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06471556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06471556, "Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06471556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*